Waters Corporation (WAT): Analyzing the Bull Case Amidst Stagnant Growth
Despite a dominant position in analytical instruments, Waters Corporation faces headwinds from a slowing Chinese market and elevated debt. We examine the investment thesis for the life sciences tools provider, weighing its recurring revenue model against current valuation concerns.